Literature DB >> 20659569

COMT gene polymorphism and corpus callosum morphometry in preterm born adults.

Anirban Dutt1, Madiha Shaikh, Taposhri Ganguly, Chiara Nosarti, Muriel Walshe, Maria Arranz, Larry Rifkin, Colm McDonald, Christopher A Chaddock, Philip McGuire, Robin M Murray, Elvira Bramon, Matthew P G Allin.   

Abstract

INTRODUCTION: Preterm birth is associated with a range of neurodevelopmental deficits, including corpus callosum (CC) abnormalities, which persist into late adolescence and early adulthood. A common single-nucleotide polymorphism in the catechol-o-methyl transferase (COMT) gene (Val158Met) is associated with cognition and brain structure and may play a role in neurodevelopment. It is not known whether this polymorphism is associated with CC morphometry in individuals born preterm.
METHODS: Structural MRI scans were acquired in 33 adults born very preterm (before 33 weeks' gestation) and 29 healthy controls. DNA was collected and COMT Val158Met polymorphism status determined using standard available assays. The mid-sagittal area of four antero-posterior subdivisions of the CC was measured. The effect of COMT Val158Met polymorphism on cross-sectional CC areas was studied using multivariate analysis and generalised linear models, adjusted for the effects of the clinical sample group (preterm vs. control), age and sex.
RESULTS: The COMT Val/Val homozygous genotype was observed to be significantly associated with reduced size of the total corpus callosum, and this relationship was present for the anterior, midposterior and posterior quarters of the CC.
CONCLUSIONS: The COMT Val158Met polymorphism possibly influences the morphometry of the corpus callosum associated with very preterm births. Further studies with larger sample sizes are warranted to conclusively establish the effects of individual genotypes of the COMT gene on corpus callosum in preterm born adults.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20659569     DOI: 10.1016/j.neuroimage.2010.07.048

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  6 in total

Review 1.  Integrative Review of Genetic Factors Influencing Neurodevelopmental Outcomes in Preterm Infants.

Authors:  Lisa M Blair; Rita H Pickler; Cindy Anderson
Journal:  Biol Res Nurs       Date:  2015-09-15       Impact factor: 2.522

2.  Altered Cerebral Curvature in Preterm Infants Is Associated with the Common Genetic Variation Related to Autism Spectrum Disorder and Lipid Metabolism.

Authors:  Hyuna Kim; Ja-Hye Ahn; Joo Young Lee; Yong Hun Jang; Young-Eun Kim; Johanna Inhyang Kim; Bung-Nyun Kim; Hyun Ju Lee
Journal:  J Clin Med       Date:  2022-05-31       Impact factor: 4.964

Review 3.  Clinical pharmacology of analgosedatives in neonates: ways to improve their safe and effective use.

Authors:  Anne Smits; John N van den Anker; Karel Allegaert
Journal:  J Pharm Pharmacol       Date:  2016-06-30       Impact factor: 3.765

4.  Statistical shape analysis of the corpus callosum in Schizophrenia.

Authors:  Shantanu H Joshi; Katherine L Narr; Owen R Philips; Keith H Nuechterlein; Robert F Asarnow; Arthur W Toga; Roger P Woods
Journal:  Neuroimage       Date:  2012-09-18       Impact factor: 6.556

5.  A latent measure explains substantial variance in white matter microstructure across the newborn human brain.

Authors:  Emma J Telford; Simon R Cox; Sue Fletcher-Watson; Devasuda Anblagan; Sarah Sparrow; Rozalia Pataky; Alan Quigley; Scott I Semple; Mark E Bastin; James P Boardman
Journal:  Brain Struct Funct       Date:  2017-06-06       Impact factor: 3.270

6.  Innovative computational approaches shed light on genetic mechanisms underlying cognitive impairment among children born extremely preterm.

Authors:  Rebecca C Fry; Yun Li; Hudson P Santos; Weifang Liu; Quan Sun; Le Huang; Arjun Bhattacharya; Geoffery W Wang; Xianming Tan; Karl C K Kuban; Robert M Joseph; T Michael O'Shea
Journal:  J Neurodev Disord       Date:  2022-03-03       Impact factor: 4.025

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.